Valuation Result
Final Brand Value

Apotea — Retail

Valuation date: 10/29/2026

Total Brand Value
SEK 741.6M
This result turns the selected legal, brand, benchmark and discount-rate assumptions into one reviewable brand value estimate.
Brand Strength
78/100
Royalty Rate
0.9%
Discount Rate
10.7%
Benchmark recommendation not unlocked for this result
Sensitivity snapshot

Quick decision check for discount rate, royalty rate and long-term growth.

WACC (Discount Rate)
10.7%
-1.0%
SEK 834.7M
10.7%
SEK 741.6M
+1.0%
SEK 667.7M
Royalty Rate
0.9%
-0.5%
SEK 345.5M
0.9%
SEK 741.6M
+0.5%
SEK 1.1B
Terminal Growth
2.0%
-0.5%
SEK 712.4M
2.0%
SEK 741.6M
+0.5%
SEK 774.4M
Brand Strength changes can also be explored to show their potential effect on brand value. Contact info@brandvaluator.se if you want to explore this for strategy, planning and budgeting.
Revenue Base
SEK 7.2B
Legal Protection
72/100
Long-term Growth
2.0%
Recommendation basis
Brand-strength range • Pro
This reference case derives its royalty rate by applying the brand-strength score to a documented industry royalty ceiling.
This valuation uses benchmark support informed by external market references and curated internal calibration.
Use this section to confirm whether the result reflects unlocked benchmark guidance or a non-benchmark method.
Forecast profile
5 years explicit forecast
High growth: 6.0%
Base growth: 3.0%
Long-term growth: 2.0%
Value build
Value for planning period: SEK 243.6M
Terminal value: SEK 498.0M
How the valuation is built

Valuation Build

Royalty Relief DCF
YearRevenueRoyaltyAfter TaxPV
Y1SEK 7,635,498,000SEK 71,468,261SEK 56,745,799SEK 53,921,491
Y2SEK 8,093,627,880SEK 75,756,357SEK 60,150,547SEK 51,608,840
Y3SEK 8,579,245,553SEK 80,301,738SEK 63,759,580SEK 49,395,377
Y4SEK 8,836,622,919SEK 82,710,791SEK 65,672,368SEK 45,938,824
Y5SEK 9,101,721,607SEK 85,192,114SEK 67,642,539SEK 42,724,151
Explicit PV (Y1–Y5)SEK 243,588,684
Terminal Value (undiscounted)SEK 788,520,539
Terminal PV (discounted)SEK 498,042,674
Total Brand ValueSEK 741,631,358

Supporting context

This section explains the evidence and judgment used to support the recommendation and the legal, brand and financial assumptions used in the valuation.

Reference case

Apotea

Prepared reference case

Indicative estimate of approximately SEK 0.74bn for the Apotea name. The royalty is constrained by the pharmacy business operating margin; it is not a quoted licence price.

Scope and capacity: the FY2025 group sales proxy includes the Norwegian Apotera business under a different customer-facing name, so the estimate may overstate the Apotea-name sales perimeter. The opening hypothetical royalty of SEK 67.4m consumes 22.6% of reported group EBIT, close to the 25%-of-profit diagnostic for all intellectual property. Logistics, assortment, technology and pharmacy permissions are separate business assets. Legal component scores are outside-in judgments, not a legal opinion.
Informed by numerous sources including company reporting, investor materials, analyst research, market data and selected benchmark references where relevant.
Key inputs
Reported = directly sourced • Estimated = selected judgment • Inferred = derived from broader evidence • Assumed = inclusion choice
Revenue perimeter
SEK 7.2033bnreported
Brand strength
78/100estimated
Royalty and 25% check
0.936%; SEK 67.4m opening royaltyestimated
Legal and rate
72/100; 10.75%estimated
Forecast and external check
6% for three years, then 3%; terminal 2%assumed
Company disclosures

These links lead to company-issued materials. BrandValuator cross-checks indicative estimates against multiple sources; the final assumptions and judgments are our own. Each input is labeled by evidence status above.

Legal Protection

trademark Status78
scope Of Rights73
risk Profile65
litigation70
contractual Rights65
goodwill Evidence81
regulatory Compliance72

Brand Strength

marketing Investment77
quality80
availability75
distinctive Brand Codes86
mental Availability84
consideration82
trust79
choice Share83
penetration79
price Elasticity62
revenue Premium64
margin Premium67
stability73